<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01755026</url>
  </required_header>
  <id_info>
    <org_study_id>H-22512</org_study_id>
    <nct_id>NCT01755026</nct_id>
  </id_info>
  <brief_title>Serum and Tissue Cefazolin Concentrations in Patients Undergoing Cesarean Delivery</brief_title>
  <official_title>Serum and Tissue Cefazolin Concentrations in Patients Undergoing Cesarean Delivery Receiving Two Differing Doses of Pre-operative Cefazolin.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Michael Stitely</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>West Virginia University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients undergoing Cesarean delivery (C-Section) with a body mass index of 35 or greater
      (this BMI number is in the obese range) will be given either 2 grams or 4 grams of an
      antibiotic before surgery. The antibiotic is intended to prevent infection from the
      surgery.It is unknown what the best dose for large women is for the usual medicine used for
      this purpose (an antibiotic medicine called cefazolin).Samples of the tissue just under the
      skin will be biopsied at the time the incision is made and at the time the cut is stitched or
      stapled closed. A sample of the muscle of the womb will be taken as the womb is stitched
      closed after the delivery. Blood tests will be done at the start and end of surgery to test
      the antibiotic level. A blood sample will be taken from the umbilical cord after the baby has
      been delivered and the umbilical cord has been cut. The umbilical cord blood sample will be
      tested for the antibiotic level.These tests will be used to find out if the usual dose of
      medicine is enough or if more medicine is needed to prevent infection in large women
      undergoing c-sections.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Actual">November 2012</completion_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cefazolin Levels</measure>
    <time_frame>2 hours</time_frame>
    <description>Cefazolin levels</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">23</enrollment>
  <condition>Cesarean Delivery</condition>
  <condition>Wound Infection</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>2 gram dose of cefazolin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2 gram dose of pre-operative cefazolin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4 gram Dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4 gram dose of pre-operative prophylaxis</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>cefazolin</intervention_name>
    <description>2 gram dose for pre-operative prophylaxis</description>
    <arm_group_label>2 gram dose of cefazolin</arm_group_label>
    <other_name>Ancef</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>cefazolin</intervention_name>
    <description>4 gram dose for pre-operative prophylaxis</description>
    <arm_group_label>4 gram Dose</arm_group_label>
    <other_name>Ancef</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 18 years or above

          2. Body mass index (BMI) of 35 or greater at the time of the first obstetric clinic visit

          3. Undergoing cesarean delivery

        Exclusion Criteria:

          1. BMI less than 35.

          2. Not undergoing Cesarean delivery.

          3. Age less than 18 years.

          4. Pre-existing infection.

          5. Allergy to cephalosporin medications or a history of an anaphylactic reaction to
             penicillin.

          6. Cesarean delivery being performed under emergent circumstances.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William H Holls, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>West Virginia University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael L Stitely, MD</last_name>
    <role>Study Chair</role>
    <affiliation>West Virginia University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>West Virginia University Hospital</name>
      <address>
        <city>Morgantown</city>
        <state>West Virginia</state>
        <zip>26506</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 29, 2011</study_first_submitted>
  <study_first_submitted_qc>December 18, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 21, 2012</study_first_posted>
  <results_first_submitted>June 12, 2013</results_first_submitted>
  <results_first_submitted_qc>June 12, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 21, 2013</results_first_posted>
  <last_update_submitted>June 12, 2013</last_update_submitted>
  <last_update_submitted_qc>June 12, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 21, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>West Virginia University</investigator_affiliation>
    <investigator_full_name>Michael Stitely</investigator_full_name>
    <investigator_title>Adjunct Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Cesarean Delivery</keyword>
  <keyword>Wound infection</keyword>
  <keyword>Obesity</keyword>
  <keyword>Prophylactic antibiotics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wound Infection</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cefazolin</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>4 Gram Dose</title>
          <description>4 gram dose of pre-operative prophylaxis</description>
        </group>
        <group group_id="P2">
          <title>2 Gram Dose of Cefazolin</title>
          <description>2 gram dose of pre-operative cefazolin</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>4 Gram Dose</title>
          <description>4 gram dose of pre-operative prophylaxis</description>
        </group>
        <group group_id="B2">
          <title>2 Gram Dose of Cefazolin</title>
          <description>2 gram dose of pre-operative cefazolin</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="11"/>
            <count group_id="B2" value="12"/>
            <count group_id="B3" value="23"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30.33" spread="4.64"/>
                    <measurement group_id="B2" value="31.09" spread="6.46"/>
                    <measurement group_id="B3" value="31" spread="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Cefazolin Levels</title>
        <description>Cefazolin levels</description>
        <time_frame>2 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>2 Gram Dose of Cefazolin</title>
            <description>2 gram dose of pre-operative cefazolin</description>
          </group>
          <group group_id="O2">
            <title>4 Gram Dose</title>
            <description>4 gram dose of pre-operative prophylaxis</description>
          </group>
        </group_list>
        <measure>
          <title>Cefazolin Levels</title>
          <description>Cefazolin levels</description>
          <units>mcg/mL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Subcutaneous tissue-opening</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.36" spread="6.68"/>
                    <measurement group_id="O2" value="40.11" spread="24.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Subcutaneous tissue-closing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.73" spread="16.02"/>
                    <measurement group_id="O2" value="34.89" spread="17.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Plasma concentration at incision</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="155.45" spread="50.97"/>
                    <measurement group_id="O2" value="346.16" spread="166.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Plasma concentration at closure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83.49" spread="34.97"/>
                    <measurement group_id="O2" value="150.12" spread="55.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Myometrial levels</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67.18" spread="13.89"/>
                    <measurement group_id="O2" value="146.22" spread="60.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Umbilical cord blood concentrations</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.01" spread="12.03"/>
                    <measurement group_id="O2" value="82.23" spread="43.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>191</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>166.01</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>4 Gram Dose</title>
          <description>4 gram dose of pre-operative prophylaxis</description>
        </group>
        <group group_id="E2">
          <title>2 Gram Dose of Cefazolin</title>
          <description>2 gram dose of pre-operative cefazolin</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Allergy</sub_title>
                <description>Minor skin reaction with starting cefazolin infusion. Administartion of cefazolin stopped with no further concerns and rash on arm resolved without further treatment.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>michael stitely</name_or_title>
      <organization>west virginia university</organization>
      <phone>304-293-5631</phone>
      <email>mstitely@hsc.wvu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

